• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗患者血浆骨桥蛋白水平的预后意义

Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention.

作者信息

Kato Ryuichi, Momiyama Yukihiko, Ohmori Reiko, Tanaka Nobukiyo, Taniguchi Hiroaki, Arakawa Koh, Nakamura Haruo, Ohsuzu Fumitaka

机构信息

First Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.

出版信息

Circ J. 2009 Jan;73(1):152-7. doi: 10.1253/circj.cj-08-0687. Epub 2008 Nov 21.

DOI:10.1253/circj.cj-08-0687
PMID:19023151
Abstract

BACKGROUND

Osteopontin (OPN) mRNA is highly expressed in atherosclerotic plaques and plasma OPN levels are high in patients with coronary artery disease and in those with restenosis. OPN-overexpressing transgenic mice show markedly increased neointimal formation after arterial injury.

METHODS AND RESULTS

The prognostic significance of the preprocedural plasma OPN level was investigated in 130 patients undergoing percutaneous coronary intervention (PCI). Patients were followed up for restenosis and major adverse cardiovascular events (MACE). At 7+/-3 months after PCI, angiography was performed again in 91 patients, of whom 40 had restenosis. Between patients with and without restenosis, OPN (492+/-200 vs 482+/-224 ng/ml) and C-reactive protein (CRP: 0.78 vs 0.70 mg/L) levels did not differ. During a 3-year follow-up, MACE occurred in 21 patients, who had higher OPN (586+/-230 vs 438+/-195 ng/ml) and CRP (1.30 vs 0.70 mg/L) levels than those without MACE (P<0.005). Both OPN and CRP levels were independent predictors for MACE. Hazard ratios for MACE were 1.3 (95% confidence interval (CI) 1.1-1.5) for a 100 ng/ml increase in OPN and 3.6 (95%CI 1.4-9.3) for CRP >1.0 mg/L.

CONCLUSIONS

In patients undergoing PCI, the preprocedural OPN and CRP levels are independent predictors for further cardiovascular events, but not for restenosis.

摘要

背景

骨桥蛋白(OPN)mRNA在动脉粥样硬化斑块中高表达,冠心病患者和再狭窄患者的血浆OPN水平升高。过表达OPN的转基因小鼠在动脉损伤后显示出新内膜形成明显增加。

方法与结果

在130例接受经皮冠状动脉介入治疗(PCI)的患者中研究了术前血浆OPN水平的预后意义。对患者进行再狭窄和主要不良心血管事件(MACE)的随访。PCI术后7±3个月,91例患者再次进行血管造影,其中40例发生再狭窄。有再狭窄和无再狭窄的患者之间,OPN(492±200 vs 482±224 ng/ml)和C反应蛋白(CRP:0.78 vs 0.70 mg/L)水平无差异。在3年的随访期间,21例患者发生了MACE,这些患者的OPN(586±230 vs 438±195 ng/ml)和CRP(1.30 vs 0.70 mg/L)水平高于未发生MACE的患者(P<0.005)。OPN和CRP水平都是MACE的独立预测因子。OPN每增加100 ng/ml,MACE的风险比为1.3(95%置信区间(CI)1.1-1.5),CRP>1.0 mg/L时为3.6(95%CI 1.4-9.3)。

结论

在接受PCI的患者中,术前OPN和CRP水平是进一步心血管事件的独立预测因子,但不是再狭窄的预测因子。

相似文献

1
Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者血浆骨桥蛋白水平的预后意义
Circ J. 2009 Jan;73(1):152-7. doi: 10.1253/circj.cj-08-0687. Epub 2008 Nov 21.
2
Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者的血清抵抗素水平与心血管事件。
J Atheroscler Thromb. 2011;18(2):108-14. doi: 10.5551/jat.6023. Epub 2010 Nov 6.
3
Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.N末端前B型利钠肽与C反应蛋白的联合作用与血管造影严重程度对预测稳定型冠状动脉疾病患者冠状动脉成形术后主要不良心血管事件和临床再狭窄的影响
Circ J. 2008 Aug;72(8):1316-23. doi: 10.1253/circj.72.1316.
4
A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.再狭窄和不良心脏事件的新型预测指标:不对称二甲基精氨酸。
Heart Vessels. 2010 Jan;25(1):19-26. doi: 10.1007/s00380-009-1158-x. Epub 2010 Jan 21.
5
Plasma levels of osteopontin before and 24 h after percutaneous coronary intervention.
Expert Opin Ther Targets. 2008 Dec;12(12):1477-80. doi: 10.1517/14728220802510740.
6
Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty.
J Cardiovasc Med (Hagerstown). 2016 Sep;17(9):687-93. doi: 10.2459/JCM.0000000000000342.
7
C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention.在接受择期冠状动脉介入治疗的患者中,血浆C反应蛋白水平而非凝血因子VII活性可预测临床结局。
Clin Cardiol. 2004 Apr;27(4):211-6. doi: 10.1002/clc.4960270407.
8
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study.接受经皮冠状动脉介入治疗的冠心病患者血浆骨桥蛋白水平与动脉粥样硬化加速:一项前瞻性临床研究
Coron Artery Dis. 2011 May;22(3):179-87. doi: 10.1097/MCA.0b013e3283441d0b.
9
[Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].血浆脑钠肽和C反应蛋白在接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者中的预后价值
Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Apr;34(4):349-52.
10
Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.冠状动脉支架置入术后,术前C反应蛋白与血管造影再狭窄或靶病变血运重建无关。
Clin Chem. 2004 Sep;50(9):1589-96. doi: 10.1373/clinchem.2004.032656. Epub 2004 Jun 17.

引用本文的文献

1
The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)-A Narrative Review.骨桥蛋白在动脉粥样硬化及其临床表现(动脉粥样硬化性心血管疾病)中的作用——一项叙述性综述
Biomedicines. 2023 Nov 29;11(12):3178. doi: 10.3390/biomedicines11123178.
2
Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease.血清骨桥蛋白和护骨素水平与外周动脉疾病血管内再通后不良结局的关系。
Cardiovasc Diabetol. 2022 Sep 1;21(1):171. doi: 10.1186/s12933-022-01605-6.
3
Ustekinumab reduces serum protein levels associated with cardiovascular risk in psoriasis vulgaris.
乌司奴单抗可降低寻常型银屑病患者与心血管风险相关的血清蛋白水平。
Exp Dermatol. 2022 Sep;31(9):1341-1351. doi: 10.1111/exd.14582. Epub 2022 May 16.
4
Osteopontin in relation to Prognosis following Coronary Artery Bypass Graft Surgery.冠状动脉搭桥手术后骨桥蛋白与预后的关系
Dis Markers. 2016;2016:1868739. doi: 10.1155/2016/1868739. Epub 2016 Aug 14.
5
Positron emission tomography imaging of coronary atherosclerosis.冠状动脉粥样硬化的正电子发射断层显像
Future Cardiol. 2016 Jul;12(4):483-96. doi: 10.2217/fca-2016-0017.
6
Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.骨桥蛋白启动子基因多态性与中国人群癌症易感性的关联:一项荟萃分析。
PLoS One. 2015 Aug 12;10(8):e0135318. doi: 10.1371/journal.pone.0135318. eCollection 2015.
7
Osteopontin predicts long-term functional outcome among ischemic stroke patients.骨桥蛋白可预测缺血性脑卒中患者的长期功能结局。
J Neurol. 2011 Mar;258(3):486-93. doi: 10.1007/s00415-010-5785-z. Epub 2010 Oct 22.
8
Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis.血浆骨桥蛋白作为冠心病的预测因子:与动脉粥样硬化的超声心动图特征的相关性。
J Clin Lab Anal. 2010;24(3):201-6. doi: 10.1002/jcla.20378.
9
Association of plasma osteopontin levels with coronary calcification evaluated by tomographic coronary calcium scoring.通过断层冠状动脉钙化评分评估血浆骨桥蛋白水平与冠状动脉钙化的关联。
J Bone Miner Metab. 2009;27(5):591-7. doi: 10.1007/s00774-009-0078-2. Epub 2009 Apr 14.